What does Portpharma do?

Portpharma is a pharmacy in Brugge. Private Limited, started on 21 October 1999, 1 establishment.

What is the address of Portpharma?

The registered office of Portpharma is located at Kustlaan 161, 8380 Brugge.

Is Portpharma still active?

Yes. According to the CBE (31 October 2026) Portpharma is active, legal situation “Normale toestand”, started on 21 October 1999.

Is Portpharma registered on Peppol?

Yes, Portpharma is registered on the Peppol network with ID 0208:0467146555.

What is the enterprise number of Portpharma?

The enterprise number of Portpharma is BE0467146555.

When was Portpharma founded?

Portpharma was founded on 21 October 1999.

Who are the directors of Portpharma?

According to the 2025 annual accounts, the directors of Portpharma are: Zeebrugge Port Services BV.

Is Portpharma a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 October 1999; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Portpharma make in 2025?

Portpharma posted a profit after taxes of € 136,837 in financial year 2025.

What is the revenue of Portpharma?

As a small company, Portpharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 290,034.

How much does an employee at Portpharma earn?

The average wage cost per full-time employee at Portpharma was € 38,800 in 2025: staff costs of € 38,810 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Portpharma have?

According to the 2025 annual accounts, Portpharma has 1 full-time equivalents (FTE).

Does Portpharma have a website?

Yes, Portpharma has a website at portpharma.be.

Portpharma (Private Limited) - Brugge - BE0467146555

Dossier Portpharma, printed on 31 October 2026 from databakkes.be/en/0467146555/portpharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Portpharma from Brugge, company number BE0467146555, closed financial year 2025 with a result of € 136,837 after tax. For that financial year Portpharma recorded a gross margin of € 290,034 and equity of € 474,955. Compared with financial year 2024, the result moved from € 131,608 to € 136,837. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 21, 2026.

What it is worth Growing

€ 474,955

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 136,837

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 339,965

▲ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

73 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

▲ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 38,810

▲ 50% vs 2024

€ 38,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,550

▲ 153% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 26 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.1 million

▼ 4% vs 2024

€ 40,667 is repaid this year. At this pace the long-term loan is gone in ≈ 26 years.

Owed to suppliers

€ 75,558

▲ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,062

▲ 50% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 279,785 Gross margin 2022: € 279,785 First fiscal year in the series	€ 295,977 Gross margin 2023: € 295,977 ▲ 6% vs 2022 (€ 279,785) Favourable step	€ 272,162 Gross margin 2024: € 272,162 ▼ 8% vs 2023 (€ 295,977) Unfavourable step	€ 290,034 Gross margin 2025: € 290,034 ▲ 7% vs 2024 (€ 272,162) Favourable step	▲ 7%
Profit after taxes	€ 171,997 Profit after taxes 2022: € 171,997 First fiscal year in the series	€ 155,581 Profit after taxes 2023: € 155,581 ▼ 10% vs 2022 (€ 171,997) Unfavourable step	€ 131,608 Profit after taxes 2024: € 131,608 ▼ 15% vs 2023 (€ 155,581) Unfavourable step	€ 136,837 Profit after taxes 2025: € 136,837 ▲ 4% vs 2024 (€ 131,608) Favourable step	▲ 4%
Equity	€ 370,929 Equity 2022: € 370,929 First fiscal year in the series	€ 406,510 Equity 2023: € 406,510 ▲ 10% vs 2022 (€ 370,929) Favourable step	€ 438,118 Equity 2024: € 438,118 ▲ 8% vs 2023 (€ 406,510) Favourable step	€ 474,955 Equity 2025: € 474,955 ▲ 8% vs 2024 (€ 438,118) Favourable step	▲ 8%
Total debts	€ 1,670,074 Total debts 2022: € 1,670,074 First fiscal year in the series	€ 1,493,546 Total debts 2023: € 1,493,546 ▼ 11% vs 2022 (€ 1,670,074) Favourable step	€ 1,460,391 Total debts 2024: € 1,460,391 ▼ 2% vs 2023 (€ 1,493,546) Favourable step	€ 1,563,497 Total debts 2025: € 1,563,497 ▲ 7% vs 2024 (€ 1,460,391) Unfavourable step	▲ 7%
Cash	€ 207,113 Cash 2022: € 207,113 First fiscal year in the series	€ 232,372 Cash 2023: € 232,372 ▲ 12% vs 2022 (€ 207,113) Favourable step	€ 256,494 Cash 2024: € 256,494 ▲ 10% vs 2023 (€ 232,372) Favourable step	€ 339,965 Cash 2025: € 339,965 ▲ 33% vs 2024 (€ 256,494) Favourable step	▲ 33%
Land & buildings	€ 531,060 Land & buildings 2022: € 531,060 First fiscal year in the series	€ 524,638 Land & buildings 2023: € 524,638 ▼ 1% vs 2022 (€ 531,060) Unchanged	€ 501,914 Land & buildings 2024: € 501,914 ▼ 4% vs 2023 (€ 524,638) Unchanged	€ 471,615 Land & buildings 2025: € 471,615 ▼ 6% vs 2024 (€ 501,914) Unchanged	▼ 6%
Retained profit	€ 350,929 Retained profit 2022: € 350,929 First fiscal year in the series	€ 386,510 Retained profit 2023: € 386,510 ▲ 10% vs 2022 (€ 350,929) Favourable step	€ 418,118 Retained profit 2024: € 418,118 ▲ 8% vs 2023 (€ 386,510) Favourable step	€ 454,955 Retained profit 2025: € 454,955 ▲ 9% vs 2024 (€ 418,118) Favourable step	▲ 9%
Dividend	€ 120,000 Dividend 2022: € 120,000 First fiscal year in the series	€ 120,000 Dividend 2023: € 120,000 Unchanged (€ 120,000) Unchanged	€ 100,000 Dividend 2024: € 100,000 ▼ 17% vs 2023 (€ 120,000) Unchanged	€ 100,000 Dividend 2025: € 100,000 Unchanged (€ 100,000) Unchanged
Bank debt	€ 1,069,172 Bank debt 2022: € 1,069,172 First fiscal year in the series	€ 1,084,517 Bank debt 2023: € 1,084,517 ▲ 1% vs 2022 (€ 1,069,172) Unfavourable step	€ 1,121,442 Bank debt 2024: € 1,121,442 ▲ 3% vs 2023 (€ 1,084,517) Unfavourable step	€ 1,075,398 Bank debt 2025: € 1,075,398 ▼ 4% vs 2024 (€ 1,121,442) Favourable step	▼ 4%
Balance sheet total	€ 2,041,003 Balance sheet total 2022: € 2,041,003 First fiscal year in the series	€ 1,900,056 Balance sheet total 2023: € 1,900,056 ▼ 7% vs 2022 (€ 2,041,003) Unchanged	€ 1,898,509 Balance sheet total 2024: € 1,898,509 Unchanged (€ 1,900,056) Unchanged	€ 2,038,451 Balance sheet total 2025: € 2,038,451 ▲ 7% vs 2024 (€ 1,898,509) Unchanged	▲ 7%
Employees (FTE)	1.2 Employees (FTE) 2022: 1.2 First fiscal year in the series	0.7 Employees (FTE) 2023: 0.7 ▼ 0.5 vs 2022 (1.2) Unchanged	0.7 Employees (FTE) 2024: 0.7 Unchanged (0.7) Unchanged	1 Employees (FTE) 2025: 1 ▲ 0.3 vs 2024 (0.7) Unchanged	▲ 0.3

Key figures of Portpharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Portpharma?

What happened at Portpharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 21, 2026 New annual accounts for financial year 2025: profit of € 136,837 (▲ 4% vs 2024). Source: NBB ↗
Oct 19, 2003 New establishment in Brugge. KBO
Oct 21, 1999 Start of the company according to the CBE. KBO

In short

From € 171,997 profit in 2022 to € 136,837 profit in 2025.

Paid € 48,106 in corporate taxes since 2022.

Best year ever: 2022, with € 171,997 profit.

On average € 290,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Zeebrugge Port Services BV

Portpharma

Apotheek Havendam 99.8%

Behind Portpharma is Zeebrugge Port Services BV. It owns 99.8% of Apotheek Havendam itself.

Directors

According to the 2025 annual accounts

Zeebrugge Port Services BV

Director · represented by Evelien De Smet

Establishments

Establishment units

Physical locations of this company

Registered office

Kustlaan 161

8380 Brugge

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

APOTHEEK HAVENDAM same network

€ 93,021 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS portpharma.be

Technologies

Cloudflare CDNJSContact Form 7ElementorFont AwesomeGSAPGoogle MapsNginxPHPRank MathSwiperWPMLWordPressjQueryjQuery UIlazysizes

Hosting & Email

Email provider

Microsoft 365

Hosting

COMBELL-AS, BE

Website info

HTTPS Ja

Languages EN, NL

Features

Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number: 0467.146.555
VAT number: BE 0467.146.555
Registered office: Kustlaan 161, 8380 Brugge
Names & denominations: Portpharma
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 October 1999
Peppol: Active · Active since 17 Feb 2025
Contact: portpharma.be
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗